Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 31, 2014

View Archived Issues

Activase given orphan drug status in U.S. for plastic bronchitis

Qiagen to develop companion diagnostics for Astellas drugs

MUSK gene associated with FADS and identified as a potential target for the disease

Pfizer offers overview of third quarter 2014

Polyphor presents new antibacterial beta-hairpin peptidomimetics

University of California at Oakland reports new gamma-secretase modulators

New compounds for tuberculosis reported by U.S. academics

Pipeline progress at Mitsubishi Tanabe Pharma during second quarter of fiscal 2014

3B Pharmaceuticals presents a novel NTR1 antagonist for imaging and targeted radiotherapy

Discovery of a novel drug target and new pharmacological agents to treat multiple myeloma

T-cell immunotherapy ATIR receives EMA orphan status for acute myeloid leukemia

Orion Pharma begins phase I study of ODM-203 in advanced solid tumors

Celgene to begin phase II study of PDA-002

KRN-23 granted orphan drug status in Europe for X-linked hypophosphatemia

Researchers discover new gene mutation implicated in salivary gland cancer

Bayer Yakuhin seeks to expand Ciproxan indications in Japan

Mutations in the TENM4 gene are associated with essential tremor

FDA grants breakthrough therapy designation to NBI-98854 for tardive dyskinesia

Critical Outcome Technologies advances pre-IND testing of COTI-2

FDA advisory committee recommends approval of Savaysa for stroke prevention in atrial fibrillation

Onxeo reports data from phase II trial of Validive for prevention of severe oral mucositis

AnaMar reports topline data from phase IIa study of AMAP-102

Auspex initiates second pivotal study of SD-809 for tardive dyskinesia

Paratek Pharmaceuticals and Transcept Pharmaceuticals complete merger

University of Michigan patents new dual MEK/PI3K inhibitors

Janssen Pharmaceutica presents new PERK inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...